Related references
Note: Only part of the references are listed.Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis
Emma Guttman-Yassky et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Managing keloid scars: From radiation therapy to actual and potential drug deliveries
Chenyu Huang et al.
INTERNATIONAL WOUND JOURNAL (2019)
Periostin is induced by IL-4/IL-13 in dermal fibroblasts and promotes RhoA/ROCK pathway-mediated TGF-β1 secretion in abnormal scar formation
Daisuke Maeda et al.
JOURNAL OF PLASTIC SURGERY AND HAND SURGERY (2019)
Gene-based evaluation of low-frequency variation and genetically-predicted gene expression impacting risk of keloid formation
Jacklyn N. Hellwege et al.
ANNALS OF HUMAN GENETICS (2018)
Keloid risk in patients with atopic dermatitis: a nationwide retrospective cohort study in Taiwan
Ying-Yi Lu et al.
BMJ OPEN (2018)
Aberrant connective tissue differentiation towards cartilage and bone underlies human keloids in African Americans
Judilyn Fuentes-Duculan et al.
EXPERIMENTAL DERMATOLOGY (2017)
Site-specific gene expression profiling as a novel strategy for unravelling keloid disease pathobiology
N. Jumper et al.
PLOS ONE (2017)
Burden of Keloid Disease: A Cross-sectional Health-related Quality of Life Assessment
Eveline Bijlard et al.
ACTA DERMATO-VENEREOLOGICA (2017)
Clinical and epidemiological analysis of keloids in Chinese patients
Wen-sheng Lu et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2015)
A genome-wide association study identifies four susceptibility loci for keloid in the Japanese population
Mitsuko Nakashima et al.
NATURE GENETICS (2010)
Share Paper
